
Fezolinetant Real-World Evidence Shows Broader Menopause Benefits
New data from the OPTION-VMS study shows fezolinetant (Veozah) improves hot flash bother, work productivity, and mood in menopausal women within 12 weeks, confirming trial results in everyday practice.













